Aaron Goodman: For my fellow histiocytic malignancy enthusiasts!

Quoting Aaron Goodman on Twitter/X:

“For my fellow histiocytic malignancy enthusiasts!
Discontinuation of BRAF/MEK inhibitors in histiocytic malignancies.
Paper has limitations – majority will relapse off continuous therapy. That being said, many patients can be safely observed.”

For the article click here.
Source: Aaron Goodman/Twitter

Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.